RBR-4sp5w6尚未招募2 期
Botulinum Toxin A for the Treatment of Hidradenitis Suppurative Axillaris: Randomized Clinical Trial
niversidade Federal de São Paulo- UNIFESP0 个研究点开始时间: 2020年5月6日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 18Y 至 —（—）
入选标准
- •18 years old or more;
- •Patients with bilateral axillary hidradenitis in the stage II-III according to Hurleys classification;
- •At least one year with the disease;
排除标准
- •Pregnant or lactating women;
- •Hypersensitivity to botulinum toxin
- •Neuromuscular diseases, such as myasthenia gravis or motor neuron disease
- •Use of aminoglycoside antibiotics or other drugs that interfere with neuromuscular transmission.
- •Patients receiving systemic treatment with immunobiological or retinoid or immunosuppressive drugs in the last 3 months.
- •Patients receiving oral antibiotic, or infiltration of corticosteroid or surgical intervention for hidradenitis in the treated area within 4 weeks of initiation of the study.
- •Patients who received botulinum toxin type A treatment in the treated area in the last 6 months.
研究者
相似试验
撤回
4 期
Botulinum Toxin-A for Hidradenitis SuppurativaHidradenitis Suppurativa \(HS\)Hidradenitis Suppurativa, Acne InversaHidradenitis SuppurativaNCT06237465Yale University30
已完成
不适用
se of Botulinum Toxin for Treatment of Idiopathic Rhinitisidiopathic rhinitisC08.460.799RBR-4jbw4sFaculdade de Medicina da Universidade de São Paulo
进行中（未招募）
不适用
Botulinumtoxin type B for plantar hyperhidrosisplantar hyperhidrosisEUCTR2009-011042-26-ATMedizinische Universität Wien, Univ.Klinik f.Neurologie
进行中（未招募）
不适用
Botulinumtoxin A Treatment in Epidermolysis Bullosa Simplex and Pachyonychia congenita-a double-blind placebo-controlled phase II proof of concept studyEUCTR2009-010763-17-SESophiahemmet
已完成
不适用
Subepithelial injection of botulinum toxin A for non-neurogecic overactive bladderon-neurogenic overactive bladderJPRN-UMIN000001422ational Center for Geriatrics & Gerontology45